The role of the gut microbiome in Alzheimer's disease

Katarzyna Łysiak; Anna Łysiak

doi:10.56782/pps.273

Data publikacji : 2024-11-21

Tom 22 Nr 4 (2024)

The role of the gut microbiome in Alzheimer's disease

Katarzyna Łysiak

Anna Łysiak

DOI: https://doi.org/10.56782/pps.273

Abstrakt

Introduction: Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive loss of memory and cognitive function. Although the etiopathogenesis of this condition is not yet fully understood, in recent years there has been a growing body of research indicating an important link between the gut microbiome and brain health, including its involvement in the pathogenesis of AD.

Aim of the article: The purpose of this article is to outline the role of the gut microbiome in the development and progression of AD, and to discuss potential therapeutic strategies resulting from a better understanding of this relationship.

State of the Art Brief: The gut microbiome, consisting of trillions of microorganisms, plays a key role in regulating immune response and neurological function through the gut-brain axis. Microbial imbalances in the gut, known as dysbiosis, can lead to chronic inflammation and increased intestinal permeability. Such conditions promote neuroinflammation, which is an important factor in the pathogenesis of AD. In addition, gut bacteria affect the production of metabolites, such as short-chain fatty acids (SCFAs), which exhibit neuroprotective properties.

Conclusions: Understanding the role of the gut microbiome in Alzheimer's disease opens up new therapeutic possibilities. Probiotics, prebiotics and dietary interventions can help restore microbial balance, reduce inflammation and improve brain health. Research on the gut microbiome may provide key information to develop innovative strategies for AD prevention and treatment.

Słowa kluczowe:

gut microbiome, Alzheimer's, brain-gut axis, neurogenesis

Inne teksty tego samego autora

Magdalena Makarewicz, Anna Łysiak, Katarzyna Łysiak, Barbara Maziarz, Evaluation of the effectiveness of platelet-rich plasma therapy in the treatment of osteoarthritis compared to other treatment methods , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)
Katarzyna Łysiak, Anna Łysiak, Barbara Maziarz, Paulina Przywara, Natalia Bogumiłło, Julia Ignacak, Kinga Ściurka, Mikołaj Borek, Oliwia Grzelak, Insomnia in the elderly and contemporary treatment methods , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)

Podobne artykuły

Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Tom 22 Nr 1 (2024)
Katarzyna Herjan, Piotr Armański, Jakub Olszewski, Magdalena Sitnik, Maciej Bara, POSITIVE IMPACT OF TRANEXAMIC ACID IN VARIOUS MEDICAL SETTINGS , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)
Sylwia Kraczkowska, Zofia Suchocka, Jan Pachecka, PODWYŻSZONE STĘŻENIE HOMOCYSTEINY WE KRWI JAKO WSKAŹNIK ZAGROŻENIA ZDROWIA , Prospects in Pharmaceutical Sciences: Tom 3 Nr 3 (2005)
Helena E. Makulska-Nowak, ALKOHOL VERSUS KANABINOLE - PORÓWNANIE SZKODLIWOŚCI , Prospects in Pharmaceutical Sciences: Tom 11 Nr 6 (2013)
Martyna Z. Wróbel, Monika Marciniak, LIGANDY RECEPTORA 5-HT1A JAKO POTENCJALNE LEKI PRZECIWDEPRESYJNE , Prospects in Pharmaceutical Sciences: Tom 13 Nr 5 (2015)
Diana Dolzhko, Natalia Melnyk, Aleksandra Kruk, Sebastian Granica, Jakub Piwowarski, Tradycyjne stosowanie ekstraktów polarnych z kwiatów lawendy – systematyczny przegląd danych literaturowych , Prospects in Pharmaceutical Sciences: Tom 22 Nr 3 (2024)
Ewelina Flegiel, english English, English English, English English, English English, English English, English English, English English, English English, English English, English , Prospects in Pharmaceutical Sciences: Tom 22 Nr 4 (2024)

Możesz również Rozpocznij zaawansowane wyszukiwanie podobieństw dla tego artykułu.

Szczegóły

Bibliografia

Statystyki

Autorzy

Pobierz pliki

PDF

Zasady cytowania

Łysiak, K., & Łysiak, A. (2024). The role of the gut microbiome in Alzheimer’s disease. Prospects in Pharmaceutical Sciences, 22(4), 81–85. https://doi.org/10.56782/pps.273

Wskaźniki altmetryczne

Cited by / Share

Licencja

Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.

Bibliografia

1. Tiwari, S.; Atluri, V.; Kaushik, A.; Yndart, A.; Nair, M. Alzheimer's disease: pathogenesis, diagnostics, and therapeutics. Int. J. Nanomed. 2019, 14, 5541-5554. DOI: 10.2147/IJN.S200490

2. Practical Medicine. Available online: https://www.mp.pl/pacjent/neurologia/choroby/151134,choroba-alzheimera. (accessed on 25.05.2024).

3. NEUROEXPERT Encyclopedia of Neurophysiology. Available online: https://neuroexpert.org/mikrobiota-jelit-a-choroba-alzheimera/ (accessed on 25.05.2024).

4. Grabrucker, S.; Marizzoni, M.; Silajdžić, E.; Lopizzo, N.; et al. Microbiota from Alzheimer's patients induce deficits in cognition and hippocampal neurogenesis. Brain 2023, 146, 4916-4934. DOI: 10.1093/brain/awad303

5. Angelucci, F.; Cechowa, K.; Amlerowa, J.; Horta, J. Antibiotics, gut microbiota, and Alzheimer’s disease. J. Neuroinflamm. 2019, 16, Art. No: 108. DOI: 10.1186/s12974-019-1494-4

6. Scheltens, P.; Strooper, B.D.; Kivipelto, M.; Holstege, H.; et al. Alzheimer’s disease. Lancet. 2021, 397, 1577–1590. DOI: 10.1016/S0140-6736(20)32205-4

7. Leszek, J. Alzheimer’s disease: current knowledge, therapeutic perspectives. Pol. Neurol. Rev. 2012, 8, 101-106.

8. Huttenhower, C.; Gevers, D.; Knight, R.; Abubucker, S.; Badger, J.H.; et al. Structure, Function and Diversity of the Healthy Human Microbiome. Nature. 2012, 486, 207–214. DOI: 10.1038/nature11234

9. Askarova S.; Umbayev, B.; Masoud, A. R.; Kaiyrlykyzy, A.; et al. The Links Between the Gut Microbiome, Aging, Modern Lifestyle and Alzheimer's Disease. Front. Cell. Infec. Microbiol. 2020, 10, Art. No: 104. DOI: 10.3389/fcimb.2020.00104

10. Rutayisire, E.; Huang, K.; Liu, Y.; et al. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol. 2016, 16, Art. No: 86. DOI: 10.1186/s12876-016-0498-0

11. Oziom, J.; Budrewicz, S. The role of intestinal microbiota in the pathogenesis and course of selected diseases of the nervous system. Pol. Neurol. Rev. 2019, 15(1), 1–11. DOI: 10.5603/PPN.2019.0005

12. Barrett, E.; Ross, R.P.; O’Toole, P.W.; et al. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J. Appl. Microbiol. 2012, 113, 411–417. DOI: 10.1111/j.1365-2672.2012.05344.x

13. Vogt, N.M.; Kerby, R.L.; Dill-McFarland, K.A.; et al. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 2017, 7, Art. No. 13537. DOI: 10.1038/s41598-017-13601-y

14. Murray, E.R.; Kemp, M.; Nguyen, T.T. The Microbiota-Gut-Brain Axis in Alzheimer’s Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions. Arch. Clin. Neuropsychol. 2022, 37, 595–607. DOI: 10.1093/arclin/acac008

15. Ghosh, T.S.; Shanahan, F.; O'Toole, P.W. The gut microbiome as a modulator of healthy ageing. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 565-584. DOI: 10.1038/s41575-022-00605-x

16. Cryan, J.F.; O'Riordan, K.J.; Cowan, C.S.M.; et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019, 99, 1877-2013. DOI: 10.1152/physrev.00018.2018

17. Bonaz, B.; Bazin, T.; Pellissier, S. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Front. Neurosci. 2018, 12, Art. No. 49 . DOI: 10.3389/fnins.2018.00049

18. Dinan, T.G.; Cryan, J.F. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol. Clin. North. Am. 2017, 46, 77–89. DOI: 10.1016/j.gtc.2016.09.007

19. Galland, L. The gut microbiome and the brain. J. Med. Food. 2014, 17, 1261–1272. DOI: 10.1089/jmf.2014.7000

20. Alam, R.; Abdolmaleky, H.M.; Zhou, J.R. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2017, 174, 651–660. DOI: 10.1002/ajmg.b.32567

21. De Lucia, C.; Murphy, T.; Maruszak, A.; et al. Serum from Older Adults Increases Apoptosis and Molecular Aging Markers in Human Hippocampal Progenitor Cells. Aging Dis. 2021, 12, 2151-2172. DOI: 10.14336/AD.2021.0409

22. Kim, T.A.; Syty, M.D.; Wu, K.; Ge, S. Adult hippocampal neurogenesis and its impairment in Alzheimer's disease. Zool. Res. 2022, 43, 481-496. DOI: 10.24272/j.issn.2095-8137.2021.479

23. Wu, G.D.; Chen, J.; Hoffmann, C.; et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011, 334, 105–108. DOI: 10.1126/science.1208344

24. McGrattan, A.M.; McGuinness, B.; McKinley, M.C.; et al. Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease. Curr. Nutr. Rep. 2019, 8, 53–65. DOI: 10.1007/s13668-019-0271-4

25. Davis, C.; Bryan, J.; Hodgson, J.; Murphy, K. Definition of the Mediterranean Diet; a Literature Review. Nutrients. 2015, 7, 9139–9153. DOI: 10.3390/nu7115459

26. Institute of Microecology. Available online: https://instytut-mikroekologii.pl/dieta-i-mikrobiota-a-choroba-alzheimera/ (accessed 01.06.2024).

27. Mosconi, L.; Murray, J.; Tsui, W. H.; Li, Y.; et al. Mediterranean diet and magnetic resonance imaging-assessed brain atrophy in cognitively Normal individuals at risk for Alzheimer's disease. J. Prev. Alzheimers Dis. 2014, 1, 23-32.

28. Flanagan, E.; Müller. M.; Hornberger, M.; Vauzour, D. Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-Related Cognitive Decline and Neurodegeneration. Curr. Nutr. Rep. 2018, 7, 49-57. DOI: 10.1007/s13668-018-0226-1

29. Devassy, J.G.; Leng, S.; Gabbs, M.; et al. Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. Adv. Nutr. 2016, 7, 905–916. DOI: 10.3945/an.116.012187

30. Morris, M.C.; Tangney, C.C.; Wang, Y.; Sacks, F.M.; et al. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015, 11, 1007-1014. DOI: 10.1016/j.jalz.2014.11.009

31. Minter, M.R.; Zhang, C.; Leone, V.; Ringus, D.L.; Zhang, X.; et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease. Sci. Rep. 2016, 6, Art. No. 30028. DOI: 10.1038/srep30028

32. Kountouras, J.; Boziki, M.; Gavalas, E.; Zavos, C.; Grigoriadis, N.; Deretzi, G, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J. Neurol. 2009, 256, 758-67. DOI: 10.1007/s00415-009-5011-z

33. Janicka, N.; Świątek, M.; Kaczmarek-Zalewska, A.; Kotarba, M.; Karolczyk, P.; Jońca, B.; Karłowicz-Bodalska, K. Obiecujące zastosowania bakterii probiotycznych jako wsparcie terapii depresji, chorób neurodegeneracyjnych – przegląd najnowszych badań. [Promising uses of probiotic bacteria as support for therapy of depression, neurodegenerative diseases - review of recent studies] Farm. Pol. 2023, 79, Art. No: 2. DOI: 10.32383/farmpol/168696

34. Akbari, E.; Asemi, Z.; Daneshvar Kakhaki, R.; Bahmani, F.; Kouchaki, E.; Tamtaji, O. R.; Hamidi, G. A. and Salami, M. Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front. Aging Neurosci. 2016, 8, Art. No: 256. DOI: 10.3389/fnagi.2016.00256.

Katarzyna Łysiak

kas.lysiak@gmail.com

Afiliacja:

a:1:{s:5:"en_US";s:140:"Stefan Cardinal Wyszynski Provincial Specialist Hospital Independent Public Health Care Center in Lublin, al. Kraśnicka 100, 20-718 Lublin ";} Poland

Anna Łysiak

ann.lysiak@gmail.com
https://orcid.org/0009-0002-1157-9081

Afiliacja:

Independent Public Clinical Hospital No. 4 in Lublin, ul. Doktora Kazimierza Jaczewskiego 8, 20-954 Lublin Poland